41.87 -0.75(-1.75%)05/17/2024
Ultragenyx Pharmaceutical Inc. (RARE)
Ultragenyx Pharmaceutical Inc. (RARE)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 05/17 16:30 | globenewswire.com |
| Ultragenyx to Participate at Bank of America's 2024 Healthcare Conference | 05/07 16:30 | globenewswire.com |
| Ultragenyx (RARE) Q1 Loss Wider Than Expected, Revenues Rise Y/Y | 05/03 13:26 | zacks.com |
| Ultragenyx (RARE) Reports Q1 Earnings: What Key Metrics Have to Say | 05/02 21:01 | zacks.com |
| Ultragenyx Pharmaceutical, Inc. (RARE) Q1 2024 Earnings Call Transcript | 05/02 20:28 | seekingalpha.com |
| Ultragenyx (RARE) Reports Q1 Loss, Lags Revenue Estimates | 05/02 18:11 | zacks.com |
| Ultragenyx Reports First Quarter 2024 Financial Results and Corporate Update | 05/02 16:00 | globenewswire.com |
| Ultragenyx Issues 2023 Corporate Responsibility Report, Showcasing Commitment to Improving Equity and Access to Innovation in Rare Disease | 04/30 16:00 | globenewswire.com |
| Ultragenyx to Host Conference Call for First Quarter 2024 Financial Results and Corporate Update | 04/25 16:30 | globenewswire.com |